Investment26 Jan 2025, 04:18 am
Sai Life Sciences Acquires 1.21 Acres of Land in Shamirpet for R&D Facility Expansion with Rs. 15 Crs. Upfront Investment
AI Summary
Sai Life Sciences Ltd. has entered into a long-term lease agreement for acquiring 1.21 acres of land along with building structures in Shamirpet, Hyderabad. The upfront investment for this acquisition is approximately Rs. 15 Crs. The company plans to create an R&D facility on the leased land, which will augment the existing Unit II Hyderabad Facility. The proposed facility is expected to be partially operational in Q4 of the financial year ending in March 2026. The investment will be funded from internal accruals.
Key Highlights
- Sai Life Sciences has acquired 1.21 acres of land in Shamirpet, Hyderabad for an R&D facility expansion.
- The upfront investment for this acquisition is approximately Rs. 15 Crs.
- The proposed R&D facility is expected to be partially operational in Q4 of the financial year ending in March 2026.
- The investment will be funded from internal accruals.
- The new R&D facility aims to augment the existing Unit II Hyderabad Facility.